GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis. - Wikidata - awgldk - TriplyDB

GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis.

GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis.

http://www.wikidata.org/entity/Q34310321

about

Application of radiation technology in vaccines development The host immune dynamics of pneumococcal colonization: implications for novel vaccine development Contribution of vaccines to our understanding of pneumococcal disease.The contribution of vaccination to global health: past, present and future.Subcutaneous Immunization with Fusion Protein DnaJ-ΔA146Ply without Additional Adjuvants Induces both Humoral and Cellular Immunity against Pneumococcal Infection Partially Depending on TLR4.Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine.Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine.Mucosal immunization with the live attenuated vaccine SPY1 induces humoral and Th2-Th17-regulatory T cell cellular immunity and protects against pneumococcal infection.Next generation pneumococcal vaccines Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response.Towards New Broader Spectrum Pneumococcal Vaccines: The Future of Pneumococcal Disease Prevention.Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity T(H)17-Mediated Protection against Pneumococcal Carriage by a Whole-Cell Vaccine Is Dependent on Toll-Like Receptor 2 and Surface Lipoproteins.Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country.Pneumonia immunization in older adults: review of vaccine effectiveness and strategies Toll-like receptor (TLR) 2 mediates inflammatory responses to oligomerized RrgA pneumococcal pilus type 1 protein.Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity.Rationale and prospects for novel pneumococcal vaccines.Cross-protective mucosal immunity mediated by memory Th17 cells against Streptococcus pneumoniae lung infection.Serotype-independent pneumococcal vaccines.Current status and perspectives on protein-based pneumococcal vaccines.Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic.Immune ageing and susceptibility to Streptococcus pneumoniae.Pneumonia and Streptococcus pneumoniae vaccine.A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi.Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.Pneumococcal whole-cell and protein-based vaccines: changing the paradigm.Development of pneumococcal vaccines over the last 10 years.The immunological mechanisms that control pneumococcal carriage.Evaluation of the role of stat3 in antibody and TH17-mediated responses to pneumococcal immunization and infection using a mouse model of Autosomal Dominant Hyper IgE Syndrome.Recent approaches in whole cell pneumococcal vaccine development: a review study.Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1.

P2860

Q26798165-A981DA3D-B014-461D-A1B5-F7E9EA9748ED Q28084920-C1E81F83-5CD0-4C4A-B717-79E5A1FA79BE Q30406750-21BC7F17-6F3D-4942-A50D-82E943D338D6 Q33624593-669FB9C3-829B-4DBB-8A3D-C2B7AD34E982 Q33785689-64AF0870-5C36-4FF8-9191-5CC9DC8CDCCF Q34298079-1B70E290-B1F8-4909-8378-32F2862947A3 Q34385066-71979C11-C9DD-47E2-A248-903637E757BA Q34890164-ABF79B16-6273-42AF-B0D6-BE0D787636F2 Q35028495-BDFBFF50-D960-4C59-BA72-B479DA991DE6 Q35181390-085AC773-95E1-4F06-97B1-23091F394F5C Q35826592-A180B606-19CD-4F3D-8DB4-4B603BF1F2D8 Q35844906-77878AEB-020F-4B49-AE93-E0E5831E2999 Q35902005-0812C9F6-DD14-416A-A987-B5E54A19A67E Q36013814-8D640A55-6F81-4F19-AC57-333C5E97BDEF Q36393396-22C1405B-7866-432F-B904-0C1E014934D7 Q36562085-26FFAD98-6B81-47EA-8D01-A9DB3D904E72 Q37103959-D9FDF736-EF92-49EB-BA5E-3AA18E3C923F Q37309218-9C4F7ECC-D0EB-44C7-AA66-18553F098F6D Q37372514-C190D465-9B47-490F-A620-DD0BB2E4AA2C Q38069943-91E36BA7-583E-437C-A3E7-1F9BFFC962B8 Q38124921-97F52759-1FBB-480C-8E57-83546B8A576B Q38255618-D81AB70E-FDC1-409A-925A-3563BD9D78E0 Q38608479-5AC86C7E-625D-4A96-A7BB-35AE2A56E92F Q39452604-9A0B1A3A-BBE9-4932-AA7A-157BC1349054 Q40291567-74D27254-26D4-419A-BAF3-5E97322E3CFA Q44398866-05CC82BE-CE03-42AD-B506-21054C817306 Q47410739-3D92724A-1003-48FE-93D5-95668E3A673F Q47658958-961D10D2-6395-4E21-A8EA-9223F7F5651E Q48364114-547BBD24-9061-43C3-BF34-38022D0737CD Q49791367-B2DAF276-3A6E-4E39-BC3B-D9C84D56C246 Q50305151-1D1BCD20-CB1B-4904-8372-FF03F9ABE004 Q51744963-A183A038-9895-4D26-9D40-133D974B025F Q52365761-E852815B-2009-43FA-A926-B5B21FD7C81D

P2860

GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis.

http://www.wikidata.org/entity/Q34310321

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

GMP-grade pneumococcal whole-c ...... n and fatal aspiration-sepsis.

@ast

GMP-grade pneumococcal whole-c ...... n and fatal aspiration-sepsis.

@en

GMP-grade pneumococcal whole-c ...... n and fatal aspiration-sepsis.

@nl

type

label

GMP-grade pneumococcal whole-c ...... n and fatal aspiration-sepsis.

@ast

GMP-grade pneumococcal whole-c ...... n and fatal aspiration-sepsis.

@en

GMP-grade pneumococcal whole-c ...... n and fatal aspiration-sepsis.

@nl

prefLabel

GMP-grade pneumococcal whole-c ...... n and fatal aspiration-sepsis.

@ast

GMP-grade pneumococcal whole-c ...... n and fatal aspiration-sepsis.

@en

GMP-grade pneumococcal whole-c ...... n and fatal aspiration-sepsis.

@nl

P1433

Q34310321-885ABCBC-464E-46F3-8181-3AD523109850

P1476

Q34310321-D94247D0-260B-4B34-8E1F-04684DB62E4B

P2093

Q34310321-00A09314-701D-4DA2-BC80-20BFE0D53DB9

Q34310321-054DCB5D-BFB5-470A-AD84-E3A54549158D

Q34310321-0EDBC7D2-4D16-4E07-A104-ED225E557639

Q34310321-1B1237A5-35F7-41A3-B1AB-2795519795FD

Q34310321-36BA314E-AB53-481B-B4EB-72A28C245F7F

Q34310321-3C664E77-C750-4B90-877A-225DCB490F2E

Q34310321-4E88167D-9D23-401F-B5EB-775AC80B62AA

Q34310321-5A2407FE-F857-42FC-89B6-686AB03BEE4F

Q34310321-798ED18E-8668-449E-AFFF-CF119C8C79A8

Q34310321-8F4B5CD6-A795-46E9-A544-53EEB26D490E

P2860

Q34310321-064BE9A8-869D-4463-8109-A60858150D8B

Q34310321-139B1319-2DC3-419D-8E41-E1845E6FF31A

Q34310321-1A08430B-7C26-4B7A-A37E-3156F438FF8F

Q34310321-27EF1CAC-068F-4C00-968A-153A0DBB8D18

Q34310321-290E8DD5-B5C7-422C-8B2B-59BB6AF85AD4

Q34310321-2D5E4DFE-0BEB-4F97-BCF5-FCD3916AF101

Q34310321-3796A949-0220-425C-B4B1-AF5007CC6D26

Q34310321-46CA35EA-0642-49D9-86EC-6DA884C3D08C

Q34310321-470DCE79-D4E8-4502-9B14-1A93EDD986F4

Q34310321-48596E50-937D-4BBC-A4EA-A7141C32EF64

P304

Q34310321-8BC4B898-C52B-4A74-8AF3-19FB353F1B52

P31

Q34310321-2A5DB4DF-1448-46E0-B0AD-32986D24F3CF

P356

Q34310321-D23D3644-1B78-4BD8-BE16-6A31FF403754

P407

Q34310321-3133C3A8-6938-4BFE-A81A-6D8EB6EFDD0D

P433

Q34310321-D8AAA301-B8E3-4140-ACBF-D06A97A710BD

P478

Q34310321-48F0CEDF-DA65-4A2B-B0C4-4676B3803253

P577

Q34310321-E44CFE83-32F9-4AE7-A06B-37E49BBBE51A

P5875

Q34310321-E6FCD47D-A20F-4920-953B-DF700E6B7152

P698

Q34310321-22CD837E-E650-48A3-90C3-EEEE1BEEEE9E

P921

Q34310321-29573274-9145-4D29-BCF2-DF6776B6FC9E

P932

Q34310321-89D26A58-1988-4C02-B885-78B78CA49D4D

P356

J.VACCINE.2010.09.031

P1433

P1476

GMP-grade pneumococcal whole-c ...... n and fatal aspiration-sepsis.

@en

P2093

Andrea Tate

http://www.w3.org/2001/XMLSchema#string

Celia Liberman

http://www.w3.org/2001/XMLSchema#string

Claudette M Thompson

http://www.w3.org/2001/XMLSchema#string

Fernando Fratelli

http://www.w3.org/2001/XMLSchema#string

George Robertson

http://www.w3.org/2001/XMLSchema#string

Jean-François Maisonneuve

http://www.w3.org/2001/XMLSchema#string

Luciana Leite

http://www.w3.org/2001/XMLSchema#string

Mark Alderson

http://www.w3.org/2001/XMLSchema#string

Porter Anderson

http://www.w3.org/2001/XMLSchema#string

Richard Malley

http://www.w3.org/2001/XMLSchema#string

P2860

Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

Pneumococcal capsular polysaccharide structure predicts serotype prevalence

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies

Interleukin-17A mediates acquired immunity to pneumococcal colonization

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine.

CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.

P304

7468-7475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2010.09.031

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46392859

http://www.w3.org/2001/XMLSchema#string

P698

20858450

http://www.w3.org/2001/XMLSchema#string

P921

P932

2981440

http://www.w3.org/2001/XMLSchema#string